◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Tsumura & Co. (4540)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-08-11
津村工业株式会社在日本和国际上从事汉方提取物中间体和颗粒汉方制剂的生产和销售。该公司提供针对女性问题、容易疲劳、皮肤问题、肠胃问题、肥胖、便秘和痔疮、以及身体疼痛、儿童疾病、压力、泌尿问题、感冒、咳嗽和鼻/喉咙炎症症状的产品。它还涉及处方药和非处方汉方药品的制造和销售。津村工业株式会社成立于 1893 年，总部位于日本东京。
机器翻译
关键数据
- 市值: JPY 280 billion
- 收入（截至 2026-03-31 财年）: JPY 192.6B
- 净利润: JPY 28.1B
- 毛利率: 47.5%
- 净利率: 14.6%
查看交互式图表与完整报表 →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| 总收入 | JPY 192.6B | JPY 181.1B | JPY 150.8B | JPY 140.0B | — |
| 毛利 | JPY 91.5B | JPY 90.6B | JPY 68.8B | JPY 68.3B | — |
| 营业利润（EBIT） | JPY 35.2B | JPY 40.1B | JPY 20.0B | JPY 20.9B | — |
| 净利 | JPY 28.1B | JPY 32.4B | JPY 16.7B | JPY 16.5B | — |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4540 交互式查看器。 /companies/us/4540
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.